The role of MAGEA2 in head and neck cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Otolaryngology - Head and Neck Surgery

• Publication date

  2011-03-21

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/archoto.2011.2PMID 21422315PMCID PMC3309612
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Melanoma antigen-11 inhibits the hypoxia-inducible factor prolyl hydroxylase 2 and activates hypoxic response.

  2009cited by this paper
• Coordinated Activation of Candidate Proto-Oncogenes and Cancer Testes Antigens via Promoter Demethylation in Head and Neck Cancer and Lung Cancer

  2009cited by this paper
• Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice.

  2009cited by this paper
• Cancer Statistics, 2008

  2008cited by this paper
• Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma

  2008cited by this paper
• TP53 mutations and survival in squamous-cell carcinoma of the head and neck.

  2007cited by this paper
• Expression of melanoma-associated antigens in oral squamous cell carcinoma.

  2007cited by this paper
• MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents.

  2006influential reference
• The p53 tumor suppressor participates in multiple cell cycle checkpoints

  2006cited by this paper
• Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

  2006cited by this paper
• Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis.

  2006cited by this paper
• Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

  2005influential reference
• Melanoma Antigen Gene Protein MAGE-11 Regulates Androgen Receptor Function by Modulating the Interdomain Interaction

  2005cited by this paper
• Cancer/testis antigens, gametogenesis and cancer

  2005cited by this paper
• DNA methylation and cancer.

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004cited by this paper
• MAGE-A1 interacts with adaptor SKIP and the deacetylase HDAC1 to repress transcription.

  2004cited by this paper
• The p53 network in head and neck cancer.

  2003cited by this paper
• Apoptosis - the p53 network

  2003cited by this paper
• A Two-Stage, p16INK4A- and p53-Dependent Keratinocyte Senescence Mechanism That Limits Replicative Potential Independent of Telomere Status

  2002cited by this paper
• Expression of melanoma antigen-encoding genes (MAGE) by common primers for MAGE-A1 to -A6 in colorectal carcinomas among Koreans.

  2002cited by this paper
• Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours

  2002cited by this paper
• Heterogeneous expression of MAGE-A genes in occult disseminated tumor cells: a novel multimarker reverse transcription-polymerase chain reaction for diagnosis of micrometastatic disease.

  2002cited by this paper
• Cancer Epigenetics and Methylation

  2002cited by this paper
• MAGE-A gene expression pattern in primary breast cancer.

  2001cited by this paper
• BAD/BCL-xL heterodimerization leads to bypass of G0/G1 arrest

  2001cited by this paper
• Immunohistochemical analysis of NY‐ESO‐1 antigen expression in normal and malignant human tissues

  2001cited by this paper
• Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.

  2001cited by this paper
• MAGE, BAGE, and GAGE gene expression in patients with esophageal squamous cell carcinoma and adenocarcinoma of the gastric cardia

  2001cited by this paper
• Expression of MAGE‐antigens in normal tissues and cancer

  2000cited by this paper
• High frequency of expression of MAGE genes in human hepatocellular carcinoma.

  1999cited by this paper
• DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter

  1999cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation.

  1996cited by this paper
• Radiation-induced cell cycle arrest compromised by p21 deficiency

  1995cited by this paper
• Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2'-deoxycytidine.

  1994cited by this paper
• A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma.

  1991cited by this paper
• Cancer statistics

  1989cited by this paper
• Cancer immunology: the search for specificity.

  1982cited by this paper
• Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture.

  1981cited by this paper

• Overexpression of MAGE-A2 is Related to the Malignant Degree and Progression of Disease in Patients With Clear Cell Renal Cell Carcinoma

  2025cites this paper
• hMAGEA2 Accelerates the Progression of Prostate Cancer via the EFNA3–Erk1/2 Signaling Pathway

  2024influential citation
• Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma

  2021cites this paper
• Expression of Cancer-testis Antigens in Adenoid Cystic Carcinoma of the Salivary Glands Correlates with Clinical Outcomes

  2021cites this paper
• Overexpression of melanoma-associated antigen A2 has a clinical significance in embryonal carcinoma and is associated with tumor progression

  2021cites this paper
• Inhibition of MAGEA2 regulates pluripotency, proliferation, apoptosis, and differentiation in mouse embryonic stem cells

  2020cites this paper
• Signature microRNAs and long noncoding RNAs in laryngeal cancer recurrence identified using a competing endogenous RNA network

  2019cites this paper
• Expression dynamics of Mage family genes during self-renewal and differentiation of mouse pluripotent stem and teratocarcinoma cells

  2019cites this paper
• Cell culture models of oral mucosal barriers: A review with a focus on applications, culture conditions and barrier properties

  2018cites this paper
• Expression of MAGE‐A and NY‐ESO‐1 cancer/testis antigens is enriched in triple‐negative invasive breast cancers

  2018cites this paper
• Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

  2018cites this paper
• Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.

  2018cites this paper
• hMAGEA2 promotes progression of breast cancer by regulating Akt and Erk1/2 pathways

  2017cites this paper
• Roles of cancer/testis antigens (CTAs) in breast cancer.

  2017cites this paper
• MAGE-A1–6   expression in patients with head and neck squamous cell carcinoma: impact on clinical patterns and oncologic outcomes

  2016cites this paper
• Clinical significance of melanoma‐associated antigen A1–6 expression in sputum of patients with squamous cell carcinoma of the larynx and hypopharynx

  2016cites this paper
• Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies

  2016cites this paper
• The adherens junction-associated protein 1 is a negative transcriptional regulator of MAGEA2, which potentiates temozolomide-induced apoptosis in GBM.

  2014cites this paper
• Antigen-specific immunotherapy in head and neck cancer

  2013cites this paper
• Expression of MAGE A1-6 and the clinical characteristics of papillary thyroid carcinoma.

  2013cites this paper
• Immuntherapie von Kopf-Hals-Karzinomen

  2013cites this paper
• Tumor-specific MAGE proteins as regulators of p53 function.

  2012cites this paper
• MAGEA4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis.

  2012cites this paper
• Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and is associated with poor disease outcome.

  2012cites this paper
• MAGEA 4 induces growth in normal oral keratinocytes by inhibiting growth arrest and apoptosis

  year unknowncites this paper